{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:11:07Z","timestamp":1789726267446,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04615-x","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T08:31:14Z","timestamp":1750321874000},"page":"4155-4167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing fosfomycin and ciprofloxacin for uncomplicated UTI treatment in adults: better bacterial eradication but non-significant clinical remission\u2014a systematic review and meta-analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Muhammad Usman","family":"Hashmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmeen","family":"Sufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamseela","family":"Zahoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hifza","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimsha","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubab","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Ramzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kundan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lava","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"1","key":"4615_CR1","doi-asserted-by":"publisher","first-page":"106018","DOI":"10.1016\/j.ijantimicag.2020.106018","volume":"56","author":"T Wang","year":"2020","unstructured":"Wang T, Wu G, Wang J, Cui Y, Ma J, Zhu Z et al (2020) Comparison of single-dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: a systematic review and meta-analysis. Int J Antimicrob Agents 56(1):106018","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"4615_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4103\/UA.UA_104_19","volume":"11","author":"NF Abou Heidar","year":"2019","unstructured":"Abou Heidar NF, Degheili JA, Yacoubian AA, Khauli RB (2019) Management of urinary tract infection in women: a practical approach for everyday practice. Urol Ann 11(4):339\u2013346","journal-title":"Urol Ann"},{"issue":"1","key":"4615_CR3","doi-asserted-by":"publisher","first-page":"e01804","DOI":"10.1128\/AAC.01804-20","volume":"65","author":"L Jakobsen","year":"2020","unstructured":"Jakobsen L, Lundberg CV, Frimodt-M\u00f8ller N (2020) Ciprofloxacin pharmacokinetics\/pharmacodynamics against susceptible and low-level resistant Escherichia coli isolates in an experimental ascending urinary tract infection model in mice. Antimicrob Agents Chemother 65(1):e01804\u2013e01820","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4615_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11845-016-1538-z","volume":"186","author":"PJ Stapleton","year":"2017","unstructured":"Stapleton PJ, Lundon DJ, McWade R, Scanlon N, Hannan MM, O\u2019Kelly F et al (2017) Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005\u20132014. Ir J Med Sci 186(3):733\u2013741","journal-title":"Ir J Med Sci"},{"issue":"3","key":"4615_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/pathogens11030356","volume":"11","author":"E Farfour","year":"2022","unstructured":"Farfour E, Dortet L, Guillard T, Chatelain N, Poisson A, Mizrahi A et al (2022) Antimicrobial resistance in Enterobacterales recovered from urinary tract infections in France. Pathogens 11(3):356","journal-title":"Pathogens"},{"issue":"3","key":"4615_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/CU9.0000000000000144","volume":"16","author":"C Baran","year":"2022","unstructured":"Baran C, K\u00fc\u00e7\u00fckcan A (2022) Antimicrobial susceptibility of bacteria isolated from urine cultures in Southern Turkey. Curr Urol 16(3):180\u2013184","journal-title":"Curr Urol"},{"issue":"1","key":"4615_CR7","doi-asserted-by":"publisher","first-page":"dlab003","DOI":"10.1093\/jacamr\/dlab003","volume":"3","author":"AK Sugianli","year":"2021","unstructured":"Sugianli AK, Ginting F, Parwati I, de Jong MD, van Leth F, Schultsz C (2021) Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review. JAC Antimicrob Resist 3(1):dlab003","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"4615_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5588\/pha.21.0071","volume":"12","author":"M Bullens","year":"2022","unstructured":"Bullens M, de Cerqueira MA, Raziq S, Lee J, Khalid GG, Khan SN et al (2022) Antibiotic resistance in patients with urinary tract infections in Pakistan. Public Health Action 12(1):48\u201352","journal-title":"Public Health Action"},{"issue":"6","key":"4615_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s10156-010-0079-z","volume":"16","author":"N Ceran","year":"2010","unstructured":"Ceran N, Mert D, Kocdogan FY, Erdem I, Adalati R, Ozyurek S et al (2010) A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. J Infect Chemother 16(6):424\u2013430","journal-title":"J Infect Chemother"},{"issue":"2","key":"4615_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciab934","volume":"75","author":"T Ten Doesschate","year":"2022","unstructured":"Ten Doesschate T, Kuiper S, van Nieuwkoop C, Hassing RJ, Ketels T, van Mens SP et al (2022) Fosfomycin vs ciprofloxacin as oral step-down treatment for Escherichia coli febrile urinary tract infections in women: a randomized, placebo-controlled, double-blind, multicenter trial. Clin Infect Dis 75(2):221\u2013229","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4615_CR11","volume":"14","author":"MM Hassan","year":"2022","unstructured":"Hassan MM, Malik M, Saleem R, Saleem A, Zohaib K, Malik AY et al (2022) Efficacy of single dose of fosfomycin versus a five-day course of ciprofloxacin in patients with uncomplicated urinary tract infection. Cureus 14(5):e24843","journal-title":"Cureus"},{"key":"4615_CR12","unstructured":"Singh I, Murtaza S, Kaur I, Agrawal V (2019) Curative efficacy of fosfomycin tromethamine versus ciprofloxacin in the initial therapy of uncomplicated UTI\u2014a prospective open-label randomised controlled clinical study. Indian J Surg [Internet]. [cited 2025 Mar 9]. Available from: https:\/\/www.semanticscholar.org\/paper\/Curative-Efficacy-of-Fosfomycin-Tromethamine-Versus-Singh-Murtaza\/e1ef4498d12ab8964d004ef5e18be9d032a78b51"},{"key":"4615_CR13","doi-asserted-by":"publisher","first-page":"658095","DOI":"10.3389\/fphar.2021.658095","volume":"12","author":"D Cao","year":"2021","unstructured":"Cao D, Shen Y, Huang Y, Chen B, Chen Z, Ai J et al (2021) Levofloxacin versus ciprofloxacin in the treatment of urinary tract infections: evidence-based analysis. Front Pharmacol 12:658095","journal-title":"Front Pharmacol"},{"issue":"3","key":"4615_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/1120009X.2021.1938949","volume":"34","author":"M Konwar","year":"2022","unstructured":"Konwar M, Gogtay NJ, Ravi R, Thatte UM, Bose D (2022) Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women\u2014a systematic review and meta-analysis. J Chemother 34(3):139\u2013148","journal-title":"J Chemother"},{"issue":"05","key":"4615_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4236\/oju.2022.125026","volume":"12","author":"S Sharmin","year":"2022","unstructured":"Sharmin S, Kamal SMM, Reza MA, Elahi KMA, Elma SMM, Habib B (2022) Fosfomycin\u2014a promising oral antibiotic for the treatment of urinary tract infection (UTI). OJU 12(05):257\u2013270","journal-title":"OJU"},{"issue":"Suppl 2","key":"4615_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0924-8579(03)00229-2","volume":"22","author":"G Kahlmeter","year":"2003","unstructured":"Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 22(Suppl 2):49\u201352","journal-title":"Int J Antimicrob Agents"},{"key":"4615_CR17","doi-asserted-by":"publisher","first-page":"2082693","DOI":"10.1155\/2016\/2082693","volume":"2016","author":"GG Zhanel","year":"2016","unstructured":"Zhanel GG, Walkty AJ, Karlowsky JA (2016) Fosfomycin: a first-line oral therapy for acute uncomplicated cystitis. Can J Infect Dis Med Microbiol 2016:2082693","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"4615_CR18","doi-asserted-by":"publisher","first-page":"8513405","DOI":"10.1155\/2020\/8513405","volume":"2020","author":"GG Zhanel","year":"2020","unstructured":"Zhanel GG, Zhanel MA, Karlowsky JA (2020) Oral and intravenous fosfomycin for the treatment of complicated urinary tract infections. Can J Infect Dis Med Microbiol 2020:8513405","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"6","key":"4615_CR19","doi-asserted-by":"publisher","first-page":"e00342","DOI":"10.1128\/AAC.00342-20","volume":"64","author":"IJ Abbott","year":"2020","unstructured":"Abbott IJ, van Gorp E, van der Meijden A, Wijma RA, Meletiadis J, Roberts JA et al (2020) Oral fosfomycin treatment for enterococcal urinary tract infections in a dynamic in vitro model. Antimicrob Agents Chemother 64(6):e00342\u2013e00420","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4615_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/JU.0000000000000620","volume":"203","author":"T Cai","year":"2020","unstructured":"Cai T, Tamanini I, Tascini C, K\u00f6ves B, Bonkat G, Gacci M et al (2020) Fosfomycin trometamol versus comparator antibiotics for the treatment of acute uncomplicated urinary tract infections in women: a systematic review and meta-analysis. J Urol 203(3):570\u2013578","journal-title":"J Urol"},{"issue":"9","key":"4615_CR21","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/jac\/dkq237","volume":"65","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI et al (2010) Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 65(9):1862\u20131877","journal-title":"J Antimicrob Chemother"},{"key":"4615_CR22","doi-asserted-by":"publisher","unstructured":"Alfaresi M, Hassan K, Alnjadat R (2019) Single-Dose Fosfomycin Trometamol Versus Other Antimicrobial Regimens For Treatment Of Uncomplicated Lower Urinary Tract Infection: A Systematic Review And Meta-Analysis. Open Microbiol J 13(1). https:\/\/doi.org\/10.2174\/1874285801913010193","DOI":"10.2174\/1874285801913010193"},{"issue":"2","key":"4615_CR23","first-page":"225","volume":"151","author":"P Guti\u00e9rrez-Castrell\u00f3n","year":"2015","unstructured":"Guti\u00e9rrez-Castrell\u00f3n P, D\u00edaz-Garc\u00eda L, de Colsa-Ranero A, Cuevas-Alpuche J, Jim\u00e9nez-Escobar I (2015) Efficacy and safety of ciprofloxacin treatment in urinary tract infections (UTIs) in adults: a systematic review with meta-analysis. Gac Med Mex 151(2):225\u2013244","journal-title":"Gac Med Mex"},{"issue":"1","key":"4615_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00345-024-04922-5","volume":"42","author":"MF Hadidi","year":"2024","unstructured":"Hadidi MF, Alhamami N, Alhakami M, Abdulhamid AS, Alsharif A, Alomari MS et al (2024) Antibiotics efficacy in clinical and microbiological cure of uncomplicated urinary tract infection: a systematic review and network meta-analysis. World J Urol 42(1):221","journal-title":"World J Urol"},{"issue":"05","key":"4615_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.53350\/pjmhs221651575","volume":"16","author":"A Tariq","year":"2022","unstructured":"Tariq A, Shaikh SA, Tariq A, Anwar Z, Shahzad QUZ, Al-Shammari RF (2022) Treatment of acute, uncomplicated urinary tract infections in children: a comparison of a single oral dosage of fosfomycin against a seven-day course of ciprofloxacin. Pak J Med Health Sci 16(05):1575","journal-title":"Pak J Med Health Sci"},{"issue":"4","key":"4615_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40121-015-0092-8","volume":"4","author":"D Iarikov","year":"2015","unstructured":"Iarikov D, Wassel R, Farley J, Nambiar S (2015) Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA adverse event reporting system database. Infect Dis Ther 4(4):433\u2013458","journal-title":"Infect Dis Ther"},{"issue":"2","key":"4615_CR27","first-page":"77","volume":"31","author":"T Mayama","year":"1993","unstructured":"Mayama T, Yokota M, Shimatani I, Ohyagi H (1993) Analysis of oral fosfomycin calcium (Fosmicin) side-effects after marketing. Int J Clin Pharmacol Ther Toxicol 31(2):77\u201382","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"6","key":"4615_CR28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/antibiotics12060971","volume":"12","author":"A Anastasia","year":"2023","unstructured":"Anastasia A, Bonura S, Rubino R, Giammanco GM, Miccich\u00e8 I, Di Pace MR et al (2023) The use of intravenous fosfomycin in clinical practice: a 5-year retrospective study in a Tertiary Hospital in Italy. Antibiotics (Basel) 12(6):971","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"4615_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","volume":"53","author":"SS Patel","year":"1997","unstructured":"Patel SS, Balfour JA, Bryson HM (1997) Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53(4):637\u2013656","journal-title":"Drugs"},{"issue":"6","key":"4615_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/pathogens12060841","volume":"12","author":"TT Chen","year":"2023","unstructured":"Chen TT, Chang YF, Wu YC (2023) Clinical use of intravenous fosfomycin in critical care patients in Taiwan. Pathogens 12(6):841","journal-title":"Pathogens"},{"issue":"2","key":"4615_CR31","doi-asserted-by":"publisher","first-page":"dlac025","DOI":"10.1093\/jacamr\/dlac025","volume":"4","author":"S Duane","year":"2022","unstructured":"Duane S, Beecher C, Vellinga A, Murphy AW, Cormican M, Smyth A et al (2022) A systematic review of the outcomes reported in the treatment of uncomplicated urinary tract infection clinical trials. JAC Antimicrob Resist 4(2):dlac025","journal-title":"JAC Antimicrob Resist"},{"issue":"sup1","key":"4615_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1120009X.2017.1380397","volume":"29","author":"E Concia","year":"2017","unstructured":"Concia E, Bragantini D, Mazzaferri F (2017) Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. J Chemother 29(sup1):19\u201328","journal-title":"J Chemother"},{"issue":"17","key":"4615_CR33","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s40265-013-0143-y","volume":"73","author":"GM Keating","year":"2013","unstructured":"Keating GM (2013) Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs 73(17):1951\u20131966","journal-title":"Drugs"},{"issue":"2","key":"4615_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/2090598X.2019.1592636","volume":"17","author":"DMO Freitas","year":"2019","unstructured":"Freitas DMO, Moreira DM (2019) Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies. Arab J Urol 17(2):114\u2013119. https:\/\/doi.org\/10.1080\/2090598X.2019.1592636 (PMID: 31285922; PMCID: PMC6600070)","journal-title":"Arab J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04615-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04615-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04615-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:08:35Z","timestamp":1761847715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04615-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4615"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04615-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}